ADIPOR1 and Insulin resistance: We have demonstrated for the first time in this study that one of these compounds, AdipoRon, acts on human AdipoR1, activates the AMPK pathway downstream, and augments the expression of mitochondria-related genes, thus improving impaired glucose tolerance and insulin resistance in vivo.